Nα-Fmoc-Nω-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-arginine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Nα-Fmoc-Nω-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-arginine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-014329
CAS number
119831-72-0
Molecular Formula
C35H42N4O7S
Molecular Weight
662.80
Nα-Fmoc-Nω-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-arginine
IUPAC Name
(2S)-5-[[amino-[(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonylamino]methylidene]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid
Synonyms
Fmoc-L-Arg(Pmc)-OH; (S)-2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-5-(3-((2,2,5,7,8-Pentamethylchroman-6-Yl)Sulfonyl)Guanidino)Pentanoic Acid
Appearance
White to off-white powder
Purity
≥ 98% (HPLC)
Density
1.35±0.1 g/cm3(Predicted)
Melting Point
70-120°C(dec.)
Storage
Store at 2-8°C
InChI
InChI=1S/C35H42N4O7S/c1-20-21(2)31(22(3)23-16-17-35(4,5)46-30(20)23)47(43,44)39-33(36)37-18-10-15-29(32(40)41)38-34(42)45-19-28-26-13-8-6-11-24(26)25-12-7-9-14-27(25)28/h6-9,11-14,28-29H,10,15-19H2,1-5H3,(H,38,42)(H,40,41)(H3,36,37,39)/t29-/m0/s1
InChI Key
QTWZCODKTSUZJN-LJAQVGFWSA-N
Canonical SMILES
CC1=C2C(=C(C(=C1C)S(=O)(=O)NC(=NCCCC(C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)N)C)CCC(O2)(C)C

Nα-Fmoc-Nω-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-arginine, a modified amino acid commonly employed in peptide synthesis and diverse biochemical applications. Here are the key applications showcasing high perplexity and burstiness:

Peptide Synthesis: Serving as a pivotal component in solid-phase peptide synthesis, this compound, with its Fmoc (Fluorenylmethyloxycarbonyl) protective group, allows for meticulous deprotection enabling the gradual addition of amino acids. This meticulous process guarantees the production of exceptionally pure peptides tailored for both research and therapeutic endeavors.

Enzymatic Studies: Widely utilized as a substrate or inhibitor in investigations focusing on arginase enzymes and nitric oxide synthase, this compound unravels crucial insights into the catalytic mechanisms and physiological functions of these enzymes. Such knowledge plays a vital role in drug discovery and deepening our understanding of disorders associated with enzyme dysregulation.

Drug Development: Within the realm of pharmaceutical research, this compound’s incorporation into peptide drug candidates enhances their stability and bioavailability. The pentamethylchroman moiety augments the pharmacokinetic properties, rendering the peptide more resistant to enzymatic breakdown. This advancement holds the promise of more potent and enduring therapeutic agents.

Bioconjugation: Enabling the formation of bioconjugates, this compound functions as a linker or functional group for attaching bioactive molecules to various carriers. This process is indispensable in crafting targeted drug delivery systems and diagnostic agents, thereby enhancing the specificity and efficacy of diverse biological applications through strategic conjugation.

1. Comparing mass spectrometric characteristics of peptides and peptoids
W Heerma, C Versluis, C G de Koster, J A Kruijtzer, I Zigrovic, R M Liskamp Rapid Commun Mass Spectrom. 1996;10(4):459-64. doi: 10.1002/(SICI)1097-0231(19960315)10:43.0.CO;2-J.
The collision-induced dissociation (CID) spectra of the [M+H]+ ions of a pentapeptide and the corresponding peptoid and retropeptoid have been compared. The spectra of the peptide and peptoid both exhibit B- and Y"-type sequence ions at identical m/z values. In contrast to the peptide, the [M+H]+ ion of the peptoid and all sequence ions containing an N-substituted glycine derivative corresponding to a tyrosine amino acid residue can easily lose a C7H6O molecule in a charge-remote fragmentation process. The presence of N-substituted glycine residues in a peptoid is further apparent from the presence of N-substituted immonium ions, which differ significantly in their fragmentation behaviour from the corresponding immonium ions observed in the spectra of common oligopeptides. Loss of the CH2 = NH imine molecule is the dominant fragmentation reaction in the CID spectra of all peptoid immonium ions investigated in this study. The elimination of the CH = NH2 ylide analogue from common peptide immonium ions is energetically less favourable as shown by ab initio calculations. The relative heat of formation of the CH = NH2 ylide neutral appeared to be 168 kJ mol-1 more than that of the CH2 = NH imine molecule.
2. Large-pore polydimethylacrylamide resin for solid-phase peptide synthesis: applications in Fmoc chemistry
J T Sparrow, N G Knieb-Cordonier, N U Obeyseskere, J S McMurray Pept Res. 1996 Nov-Dec;9(6):297-304.
We have synthesized a hydrophilic crosslinked aminoalkyl polydimethylacrylamide-beaded support upon which peptides have been assembled using standard Fmoc chemistry in automated batch-wise equipment. The resin was prepared by the free radical-initiated co-polymerization of N,N-dimethylacryl-amide, N,N'-bisacrylyl-1,3-diaminopropane and a functional monomer N-methacrylyl-1,3-diaminopropane hydrochlorid. After coupling of N-alpha-tert-butyloxycarbonyl-glycine (Boc-glycine), amino acid analyses gave resin loading capacities of 0.66 mmol/g. The resulting polymer was highly swollen by polar solvents including aqueous buffers and had an exclusion limit of 50 kDa for soluble proteins. This resin was found to be an excellent support for peptide synthesis using Fmoc chemistry. Typical purities of crude peptides were 80%-95%, including sequences that failed on conventional polystyrene resins.
3. Efficient solid phase synthesis of mixed Thr(P)-, Ser(P)- and Tyr(P)-containing phosphopeptides by "global" "phosphite-triester" phosphorylation
J W Perich Int J Pept Protein Res. 1992 Aug;40(2):134-40.
The synthesis of the mixed Thr(P)/Tyr(P)-containing peptide, Ala-Thr(P)-Tyr(P)-Ser-Ala, was accomplished by "phosphite-triester" phosphorylation of the resin-bound Thr/Tyr-containing peptide using di-t-butyl N,N-diethylphosphoramidite as the phosphitylation reagent. The pentapeptide-resin was assembled by Fmoc/solid-phase peptide synthesis with the use of PyBOP as coupling reagent and the hydroxy-amino acids incorporated as side-chain free Fmoc-Tyr-OH and Fmoc-Thr-OH. "Global" bis-phosphorylation of the peptide-resin was accomplished by treatment with di-t-butyl N,N-diethylphosphoramidite/1H-tetrazole followed by m-chloroperoxybenzoic acid oxidation of the intermediate di-t-butylphosphite triester. Simultaneous peptide-resin cleavage and peptide deprotection was effected by treatment of the peptide-resin with 5% anisole/TFA and gave the Thr(P)/Tyr(P)-containing phosphopeptide in high yield and purity. In addition, the tyrosyl residue was found to be phosphitylated in preference to the threonyl residue since the phosphitylation of the pentapeptide-resin using only 1.1 equiv. of di-t-butyl N,N-diethylphosphoramidite gave Ala-Thr-Tyr(P)-Ser-Ala as the major product and both Ala-Thr(P)-Tyr(P)-Ser-Ala and Ala-Thr-Tyr-Ser-Ala as minor products.
Online Inquiry
Verification code
Inquiry Basket